Ontology highlight
ABSTRACT:
SUBMITTER: Hossian AKMN
PROVIDER: S-EPMC9077369 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature
Hossian A K M Nawshad AKMN Hackett Christopher S CS Brentjens Renier J RJ Rafiq Sarwish S
Molecular therapy : the journal of the American Society of Gene Therapy 20220211 4
T cells genetically engineered to recognize and eliminate tumor cells through synthetic chimeric antigen receptors (CARs) have demonstrated remarkable clinical efficacy against B cell leukemia over the past decade. This therapy is a form of highly personalized medicine that involves genetically modifying a patient's T cells to recognize and kill cancer cells. With the FDA approval of 5 CAR T cell products, this approach has been validated as a powerful new drug in the therapeutic armamentarium a ...[more]